样式: 排序: IF: - GO 导出 标记为已读
-
Complexity of Trials on Pain Management in Acute Pancreatitis: An Ongoing Challenge Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-16 Sivesh K. Kamarajah, Graeme Maclennan, Sanjay Pandanaboyana
-
The Role of Advanced Practice Providers in Modern Gastroenterology Practice Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-16 Sarah Enslin PA-C, Vivek Kaul MD AGAF
-
One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-13 Marisa G. Stahl, Zhaoxing Pan, Monique Germone, Sadie Nagle, Pooja Mehta, Mary Shull, Isabel Griffith, Brianne Shuler, Edward Hoffenberg, Iman Taki, Cristy Geno-Rasmussen, Marian J. Rewers, Jill M. Norris, Edwin Liu, ASK Study Group
Celiac disease (CD) mass screening remains controversial in part because of a paucity of data to support its benefit. The Autoimmunity Screening for Kids study is a mass screening study for pediatric CD and type 1 diabetes in Colorado. This study prospectively follows up children ages 1 to 17 years who screened positive for tissue transglutaminase IgA autoantibodies in the Autoimmunity Screening for
-
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-13 Susumu Hijioka, Daiki Yamashige, Minoru Esaki, Goro Honda, Ryota Higuchi, Toshihiko Masui, Yasuhiro Shimizu, Masayuki Ohtsuka, Yusuke Kumamoto, Akio Katanuma, Naoto Gotohda, Hirofumi Akita, Michiaki Unno, Itaru Endo, Yukihiro Yokoyama, Suguru Yamada, Ippei Matsumoto, Takao Ohtsuka, Satoshi Hirano, Hiroaki Yasuda, Manabu Kawai, Taku Aoki, Masafumi Nakamura, Daisuke Hashimoto, Toshiki Rikiyama, Akihiko
-
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-10 Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs
-
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-10 Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito Itoh
-
Rise in First-Time ERCP For Benign Indications >1 Year After Cholecystectomy Is Associated With Worse Outcomes Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-09 Nikhil R. Thiruvengadam, Monica Saumoy, Douglas E. Schaubel, Peter B. Cotton, B. Joseph Elmunzer, Martin L. Freeman, Shyam Varadarajulu, Michael L. Kochman, Gregory A. Coté
-
Value of Ammonia Testing in Clinical Practice Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-07 Maria Pilar Ballester, Juan Antonio Carbonell-Asins, Thomas Reiberger
-
Long-Term Outcomes of Endoscopic Ultrasound–Guided Ablation Vs Surgery for Pancreatic Cystic Tumors Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-06 Sung Hyun Cho, Dong-Wan Seo, Dongwook Oh, Tae Jun Song, Sung Koo Lee
-
Number of Older Biological Siblings and Early-Onset Colorectal Cancer Risk Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-06 Noah C. Peeri, Peter S. Liang, Kelli O’Connell, David A. Katzka, Elizabeth D. Kantor, Mengmeng Du
-
Nature and Nurture in Familial Aggregation of Steatotic Liver Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-06 Juho Asteljoki, Panu K. Luukkonen
-
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-06 Kasper A. Overbeek, Djuna L. Cahen, Marco J. Bruno
-
Prevalence and Costs of Esophageal Strictures in the United States Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-06 Angela Z. Xue, Chelsea Anderson, Cary C. Cotton, Charles E. Gaber, Cynthia Feltner, Evan S. Dellon
Esophageal strictures are a leading cause of dysphagia, but data regarding the epidemiology of esophageal strictures are limited. This study aimed to investigate the prevalence, health care utilization, and financial burden of esophageal strictures in the United States. We performed a retrospective cohort study using 2 large national insurance claims databases (MarketScan and Medicare). Using International
-
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-05 Ani Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, Susanna Naggie, Mark S. Sulkowski, Tinsay Woreta, Jordan E. Lake, Holly Crandall, Rohit Loomba, Laura A. Wilson, Richard K. Sterling, Sonya Heath, Samer Gawrieh, Naga P. Chalasani, Jennifer C. Price, HIV NASH Clinical Research Network, Susanna Naggie MD MHS, Anna Mae Diehl MD, Mariko Kopping MS RD, Rebecca Mangus RRT BSRT, Naga Chalasani MD, Kaelea
Food insecurity (FI) is a risk factor for nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis in the general population, but its impact on liver disease in people with HIV (PWH) is unknown. We examined the association of FI with prevalence of NAFLD and fibrosis in a diverse cohort of PWH. PWH aged 18 years on antiretroviral therapy, HIV RNA <200 copies/mL, and without other known liver diseases
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-05 Anthony Kerbage, Jean-Paul Achkar, Carol Rouphael
-
Optimizing Helicobacter pylori Eradication Therapies: From Trial to Real World Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-04 Qingzhou Kong, Kunping Ju, Yueyue Li
-
Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-03 Stephen A. Firkins, Joy Yates, Neehal Shukla, Rajat Garg, John J. Vargo, Anthony Lembo, Cleveland Clinic Obesity Medicine and Bariatric Endoscopy Working Group, Roberto Simons-Linares MD, W. Scott Butsch MD
-
Barriers to Community-Based Eradication of Helicobacter pylori Infection Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-04-03 Shria Kumar, Manuela Araque, Valerie S. Stark, Leo S. Kleyman, Damian A. Cohen, David S. Goldberg
-
Artificial Intelligence and Medical Liability in Gastrointestinal Endoscopy Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-30 Sami Elamin, Mindy Duffourc, Tyler M. Berzin, Mark E. Geissler, Sara Gerke
-
Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-29 Edward L. Barnes, Anastasia Karachalia Sandri, Hans H. Herfarth, Tine Jess
-
A Reassessment of Misclassifications in Metabolic Dysfunction–Associated Steatotic Liver Disease: Points to Consider Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-29 Shuhao Zheng, Lei Xu
-
The Comparative Efficacy of Buprenorphine to Diclofenac for Pain Control in Acute Pancreatitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-29 Hsueh-Chien Chiang
-
Impact of Endoscopic Treatment in Severe Duodenal Polyposis: A National Study in Familial Adenomatous Polyposis Patients Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-28 Pierrine Le Bras, Estelle Cauchin, Glenn De Lange, Driffa Moussata, Géraldine-Anne Garcia, Lucille Quénéhervé, Jean-Christophe Saurin, Emmanuel Coron
The majority of patients with familial adenomatous polyposis (FAP) develop duodenal adenomas with a risk of progression to duodenal cancer. Endoscopic management of FAP duodenal adenomas has been proposed as a less-invasive option than surgery, but available data still are limited. Our aims were to assess the feasibility and safety of endoscopic treatment in duodenal polyposis and to evaluate its long-term
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-26 Sheila D. Rustgi MD, Shailja C. Shah MD MPH
-
Best Practices for Educating in Gastroenterology Fellowship: A Primer on Instruction Vs Coaching Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-26 Sasha Kapil, John J. Guardiola, Indira Bhavsar-Burke
-
Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-26 David A. Lieberman, The AGA CRC Workshop Panel, Aasma Shaukat, Folasade P. May, John M. Carethers, Iris Lansdorp-Vogelaar, Uri Ladabaum, Timothy R. Church, Anjelica Davis, Chyke A. Doubeni, John M. Inadomi, Richard C. Wender, Pedro Nascimento de Lima, Rosita van den Puttelaar
-
The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-21 Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price, Soroor Owrangi, Nagashree Gundu-Rao, Romona Satchi, James M. Paik
-
Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-21 Shanshan Wu, Zhirong Yang, Si Liu, Qian Zhang, Shutian Zhang, Shengtao Zhu
-
Behavioral Therapy for Functional Heartburn: Recommendation Statements Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-20 Livia Guadagnoli, Rena Yadlapati, John Pandolfino, Alyse Bedell, Anjali U. Pandit, Kerry B. Dunbar, Ronnie Fass, Richard Gevirtz, C. Prakash Gyawali, Stephen E. Lupe, Megan Petrik, Megan E. Riehl, Jessica Salwen-Deremer, Madison Simons, Kathryn N. Tomasino, Tiffany Taft
Brain-gut behavior therapies (BGBT) are increasingly recognized as effective therapeutic interventions for functional heartburn. However, recommendations regarding candidacy for treatment, initial treatment selection, and navigating treatment non-response have not been established for functional heartburn specifically. The aim of this study was to establish expert-based recommendations for behavioral
-
Endometriosis Is Associated with Higher Healthcare Utilization and Upper Gastrointestinal Symptoms Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Madison Simons, Michael Cline, Ashley Gubbels, Cara King, Anthony Lembo, Stephen Lupe
-
Algorithm Training and Testing for a Nonendoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Prasad G. Iyer, Seth W. Slettedahl, Douglas W. Mahoney, Maria Giakoumopoulos, Marilyn C. Olson, Martin Krockenberger, William R. Taylor, Patrick Foote, Calise Berger, Cadman Leggett, Tsung-Teh Wu, Eduardo Antpack, Gary W. Falk, Gregory G. Ginsberg, Julian A. Abrams, Charles J. Lightdale, Francisco Ramirez, Allon Kahn, Herbert Wolfsen, Vani Konda, Arvind J. Trindade, John B. Kisiel
-
Severe Fatigue in Inflammatory Bowel Disease: Dopaminergic Therapy With Modafinil or Vitamin Therapy With Thiamine Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Palle Bager, Christian L. Hvas, Jens Frederik Dahlerup
-
Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Jean-Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, Francesca Bresso, Lena Thin, Remo Panaccione, Rogério Serafim Parra, Sharanya Ford, Valencia P. Remple, Ana Paula Lacerda, Samuel I. Anyanwu, Madhuja Mallick, Andrew Garrison, Miguel Regueiro
-
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Laurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, Raja Atreya, David T. Rubin, James O. Lindsay, Jesse Siffledeen, Dana J. Lukin, John Wright, Kenji Watanabe, Sharanya Ford, Valencia P. Remple, Ana P. Lacerda, Elena Dubcenco, Andrew Garrison, Qian Zhou, Sofie Berg, Samuel I. Anyanwu, Stefan Schreiber
-
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Ralley Prentice, Emma Flanagan, Emily K. Wright, Peter R. Gibson, Sam Rosella, Ourania Rosella, Jakob Begun, Yoon-Kyo An, Ian C. Lawrance, Michael A. Kamm, Miles Sparrow, Rimma Goldberg, Lani Prideaux, Sara Vogrin, Katerina V. Kiburg, Alyson L. Ross, Megan Burns, Sally J. Bell
-
Esophageal Enigma: Isolated Lower Esophageal Sphincter Amyloidosis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Alam Merchant, Raul S. Gonzalez, Anand Jain
-
Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Jeong-Ju Yoo, Young-Gi Song, Ji Eun Moon, Young Seok Kim, Sang Gyune Kim
-
Risk of Cancer in Patients With Diverticular Disease: A Population-Based Cohort Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Frederikke S. Troelsen, Dóra K. Farkas, Rune Erichsen, Lisa L. Strate, John A. Baron, Henrik T. Sørensen
Several studies have investigated the association between diverticular disease (DD) and colorectal cancer. However, whether there is an association between DD and malignancies other than those in the colorectum remains uncertain. For the 1978–2019 period, we conducted a nationwide, population-based cohort study using national Danish health care data. We followed patients with DD for up to 20 years
-
Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-10 Amrit K. Kamboj, Dhyanesh A. Patel, Rena Yadlapati
-
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-04 Stephen A. Harrison, Juan P. Frias, K. Jean Lucas, Gary Reiss, Guy Neff, Sureka Bollepalli, Yan Su, Doreen Chan, Erik J. Tillman, Ali Moulton, Brittany de Temple, Arian Zari, Reshma Shringarpure, Timothy Rolph, Andrew Cheng, Kitty Yale
-
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-02 Duco T. Mülder, Anne I. Hahn, Robert J. Huang, Margaret J. Zhou, Benjamin Blake, Omonefe Omofuma, John D. Murphy, Daniela S. Gutiérrez-Torres, Ann G. Zauber, James F. O’Mahony, M. Constanza Camargo, Uri Ladabaum, Jennifer M. Yeh, Chin Hur, Iris Lansdorp-Vogelaar, Reinier Meester, Monika Laszkowska
-
The Efficacy of Real-time Computer-aided Detection of Colonic Neoplasia in Community Practice: A Pragmatic Randomized Controlled Trial Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-02 Nikhil R. Thiruvengadam, Pejman Solaimani, Manish Shrestha, Seth Buller, Rachel Carson, Breanna Reyes-Garcia, Ronaldo D. Gnass, Bing Wang, Natalie Albasha, Paul Leonor, Monica Saumoy, Raul Coimbra, Arnold Tabuenca, Wichit Srikureja, Steve Serrao
-
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Pojsakorn Danpanichkul, Cheng Han Ng, Darren Jun Hao Tan, Karn Wijarnpreecha, Daniel Q. Huang, Mazen Noureddin, Young Alcohol Disease Collaborative, Benjamin Nah, Jia Hong Koh, Margaret Teng, Wen Hui Lim, Vijay Ramadoss, Elizabeth Thong, Mark Muthiah, Zhen Yu Wong, Apichat Kaewdech, Kwanjit Duangsonk, Ken Liu, Tomoya Sano, Hirokazu Takahashi, Vincent Chen, Brian P. Lee
-
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Anouk M. Wijnands, Bas B.L. Penning de Vries, Maurice W.M.D. Lutgens, Zeinab Bakhshi, Ibrahim Al Bakir, Laurent Beaugerie, Charles N. Bernstein, Ryan Chang-ho Choi, Nayantara Coelho-Prabhu, Trevor A. Graham, Ailsa L. Hart, Joren R. ten Hove, Steven H. Itzkowitz, Julien Kirchgesner, Erik Mooiweer, Seth R. Shaffer, Shailja C. Shah, Sjoerd G. Elias, Bas Oldenburg, Dutch Initiative on Crohn and Colitis
-
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Madeleine Chang, Devon Chang, Sudha Kodali, Stephen A. Harrison, Mark Ghobrial, Naim Alkhouri, Mazen Noureddin
-
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Jordan E. Axelrad MD MPH, David T. Rubin MD
-
Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Jasmohan S. Bajaj, Nikolaos T. Pyrsopoulos, Robert S. Rahimi, Zeev Heimanson, Christopher Allen, Don C. Rockey
-
Phosphatidylethanol Detects Occult Heavy Alcohol Use in Patients With Acute and Chronic Pancreatitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Nicole Wong, Cihang Gu, Dhiraj Yadav, Gregory A. Cote, Oregon Pitt Pancreatology Working Group, Emily Jonica, Saad Jazrawi, Melissa Saul, Kaveh Sharzehi, Jessica Yu
-
White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States–Removing Barriers and Embracing Opportunities Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 M. Anthony Sofia, Joseph D. Feuerstein, Leslie Narramore, Karen A. Chachu, Sarah Streett
Despite incredible growth in systems of care and rapidly expanding therapeutic options for people with inflammatory bowel disease, there are significant barriers that prevent patients from benefiting from these advances. These barriers include restrictions in the form of prior authorization, step therapy, and prescription drug coverage. Furthermore, inadequate use of multidisciplinary care and inflammatory
-
Emotional Intelligence: An Impactful Yet Often Overlooked Skill That Can Enhance Physician Well-being and Professional Satisfaction Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 David J. Hass, Marc A. Brackett
-
Antibiotic Exposure and Risk of New-Onset Inflammatory Bowel Disease: A Systematic Review and Dose-Response Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Ruqiao Duan, Cunzheng Zhang, Gaonan Li, Jun Li, Liping Duan
-
Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Ana Vilela, Elit Quingalahua, Alejandra Vargas, Fadi Hawa, Carol Shannon, Eileen S. Carpenter, Jiaqi Shi, Somashekar G. Krishna, Un-Jung Lee, Jean M. Chalhoub, Jorge D. Machicado
-
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Neeraj Narula, Emily C.L. Wong, Parambir S. Dulai, Jaiminkumar Patel, John K. Marshall, Clara Yzet, Vipul Jairath, Ryan Ungaro, Jean-Frederic Colombel, Walter Reinisch, the CALM LTE investigators
-
MALT Lymphoma of the Esophagus Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-27 Jingjing Lian, Aiping Xu, Meidong Xu
-
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-27 Vivek C. Goodoory, Mais Khasawneh, Christopher J. Black, Alexander C. Ford
The gold standard symptom-based criteria for diagnosis of irritable bowel syndrome (IBS) are the Rome IV criteria. These are more restrictive than their predecessor, Rome III, because the cardinal feature required to meet criteria for IBS was changed to presence of abdominal pain alone, rather than abdominal pain or discomfort. This change was made because discomfort was believed to be an ambiguous
-
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized Patients Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-23 Michael Li, Danny Wong, Jordan S. Sack, Alexander S. Vogel, F. Stephen Hodi, Lawrence Fong, Jennifer C. Lai, Stephen D. Zucker, Shilpa Grover
-
AGA Clinical Practice Update on High-Quality Upper Endoscopy: Expert Review Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-22 Satish Nagula, Sravanthi Parasa, Loren Laine, Shailja C. Shah
The purpose of this Clinical Practice Update (CPU) Expert Review is to provide clinicians with guidance on best practices for performing a high-quality upper endoscopic exam. The best practice advice statements presented herein were developed from a combination of available evidence from published literature, guidelines, and consensus-based expert opinion. No formal rating of the strength or quality
-
-